Sherry Bullens

发表

Prednisolone Does Not Regulate Factor VIII Expression in Mice Receiving AAV5-hFVIII-SQ: Valoctocogene Roxaparvovec

S. Sisó, S. Bunting, S. Fong, 2019, Molecular therapy. Methods & clinical development.

Molecular Imaging of the Initial Inflammatory Response in Atherosclerosis: Implications for Early Detection of Disease

S. Bunting, J. Lindner, B. Kaufmann, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Cardiovascular and Systemic Microvascular Effects of Anti-vascular Endothelial Growth Factor Therapy for Cancer

S. Bunting, J. Lindner, B. Kaufmann, 2022 .

Pharmacokinetics and Biodistribution of a Human Monoclonal Antibody to Oxidized LDL in Cynomolgus Monkey Using PET Imaging

S. Cherry, S. Rendig, C. Griesemer, 2012, PloS one.

Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency

S. Bunting, Britta Handyside, Sherry Bullens, 2020, Journal of Biological Chemistry.

Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice

S. Bunting, S. Fong, Britta Handyside, 2019, The Journal of Biological Chemistry.

Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB

P. Fitzpatrick, S. Bunting, A. Bagri, 2014, Proceedings of the National Academy of Sciences.

Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia.

A. Munnich, S. Bunting, C. O’Neill, 2012, American journal of human genetics.

Young mice administered adult doses of AAV5-hFVIII-SQ achieve therapeutic factor VIII expression into adulthood

S. Sisó, S. Bunting, S. Fong, 2022, Molecular therapy. Methods & clinical development.

Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice

S. Bunting, S. Fong, B. Carter, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Levels of Human FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice Following Gene Therapy with BMN 270

Carter, S. Bunting, S. Fong, 2017 .

Vector genome loss and epigenetic modifications mediate decline in transgene expression of AAV5 vectors produced in mammalian and insect cells

S. Bunting, S. Fong, A. M. Ismail, 2022 .

Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter

Guoying Yu, J. Vowinckel, S. Bunting, 2020, Molecular therapy. Methods & clinical development.

Neutral Endopeptidase-Resistant C-Type Natriuretic Peptide Variant Represents a New Therapeutic Approach for Treatment of Fibroblast Growth Factor Receptor 3–Related Dwarfism

D. Rimoin, W. Wilcox, S. Bunting, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice

P. Fitzpatrick, S. Bunting, Catherine Vitelli, 2017, Molecular therapy. Methods & clinical development.

Intracerebroventricular dosing of N-sulfoglucosamine sulfohydrolase in mucopolysaccharidosis IIIA mice reduces markers of brain lysosomal dysfunction

S. Bunting, S. Fong, Britta Handyside, 2022, The Journal of biological chemistry.